Dysthyroid Optic Neuropathy: Treatment with Additional Intravenous Methylprednisolone Pulses after the Basic Schedule Is Associated with Stabilization or Further Improvement of Clinical Outcome

Background: Dysthyroid optic neuropathy (DON) is a sight-threatening complication of Graves’ orbitopathy (GO). Treatment of DON consists of the urgent administration of intravenous methylprednisolone (ivMP) in very high doses followed by orbital decompression if the response is poor or absent. It is...

Descripción completa

Detalles Bibliográficos
Autores principales: Pelewicz, Maryla, Rymuza, Joanna, Pelewicz, Katarzyna, Miśkiewicz, Piotr
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9026539/
https://www.ncbi.nlm.nih.gov/pubmed/35456161
http://dx.doi.org/10.3390/jcm11082068

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9026539/
https://www.ncbi.nlm.nih.gov/pubmed/35456161
http://dx.doi.org/10.3390/jcm11082068

Ejemplares similares